By inhibiting cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) or programmed death protein-1 (PD-1), T-cells enhance the body's immune response to fighting cancer cells, protecting against autoimmunity, and simultaneously maintaining self-tolerance. This evidence concerns the gene PDCD1 and cancer.